July 2023 registered direct ordinary share warrants
Issued 2023
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: X-Ray Apparatus & Tubes & Related Irradiation ApparatusIndustry: Medical - DevicesCountry: ILExchange: Nasdaq
DilutionScan read 22 of Nano-X Imaging Ltd.'s SEC filings and found 4 warrant series, 1 ATM program, 1 shelf registration and 2 completed offerings on file for NNOX. The latest dilution event on file is an offering on Aug 7, 2026. Analysis updated Oct 4, 2026.
NNOX
Going-concern warning and tight cash runway
Nano-X is a medical imaging company in severe financial distress. It generated $13.0M in revenue in FY 2025, up 15.4% from the prior year, but lost $75.0M in net income. The core hardware business has negative gross margins, meaning the company loses money on every unit it sells, while heavy R&D spending of $19.2M (148% of revenue) drives the headline losses.
Raise routes on file: active ATM + effective shelf · latest dilution event 88 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 7, 2026 · Offering
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2023
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2026
Shares Underlying
Exercise Price
Issued 2019
Shares Underlying
Exercise Price
Issued 2024
Total capacity
Sold to date
Issued 2026
Total capacity
Remaining
Gross proceeds
Price per share
Issued 2026
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Medical - Devices. All tickers A to Z